Contrast Enhanced Ultrasound (CEUS) Market Size, Share and Growth Outlook, 2026

Contrast Enhanced Ultrasound (CEUS) Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Contrast Enhanced Ultrasound (CEUS) Market size is forecast to increase from $2.95 Billion in 2026 to $4.56 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034.

The Contrast Enhanced Ultrasound (CEUS) market report provides detailed analysis and outlook of Contrast Enhanced Ultrasound (CEUS) segments including By Product Type (Diagnostic Ultrasound Equipment, Ultrasound Contrast Agents ), By Technology Platform (Non-Targeted CEUS, Targeted CEUS), By Clinical Application (Cardiovascular Imaging, Hepatic & Biliary, Oncology, Renal and Urological Imaging, Obstetric and Gynecological Imaging), By End-User (Hospitals and Multi-Specialty Health Systems, Diagnostic Imaging Centers, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Contrast Enhanced Ultrasound (CEUS) Industry Overview

Advanced Imaging Applications Expanding the Role of CEUS

The Contrast Enhanced Ultrasound (CEUS) industry is experiencing significant advancement as healthcare providers increasingly adopt ultrasound-based imaging solutions for oncology, hepatology, cardiology, and precision medicine applications. CEUS utilizes specialized microbubble contrast agents to provide detailed visualization of tissue perfusion, vascular structures, and microcirculatory dynamics in real time. The technology is gaining recognition as a radiation-free, cost-effective alternative to conventional imaging modalities while offering enhanced diagnostic accuracy and procedural guidance capabilities.

Quantitative Imaging Enhancing Liver Disease Assessment

Clinical research is driving the evolution of CEUS from traditional anatomical imaging toward advanced quantitative assessment techniques. Medical investigators have demonstrated the effectiveness of combining ultrasound-guided attenuation parameters with microbubble contrast agents to evaluate complex liver lesions and monitor metabolic dysfunction-associated steatotic liver disease (MASLD). This approach provides a highly precise, non-invasive, and radiation-free method for characterizing liver abnormalities and assessing disease progression. The growing use of quantitative CEUS metrics is expanding its value in hepatology, where accurate disease monitoring and lesion characterization are essential for treatment planning and patient management.

Emerging Oncology Applications Supporting Precision Medicine

The application of CEUS in oncology is expanding beyond perfusion imaging into advanced cellular and therapeutic monitoring. Collaborative research initiatives successfully demonstrated the use of lipid-shell nanobubbles containing C4F10 gas cores to track CAR-T cell distribution within solid tumors. The study showed that immune cells can internalize engineered ultrasound contrast agents, allowing clinicians to monitor cellular trafficking in real time using contrast-enhanced ultrasound. This innovation offers a lower-cost, radiation-free alternative to PET and MRI-based tracking methods while supporting the development of personalized immunotherapy monitoring strategies.

Real-Time Treatment Monitoring Advancing Clinical Decision-Making

The integration of Contrast Enhanced Ultrasound with Super-Resolution Ultrasound technologies is transforming ultrasound into a dynamic treatment management tool. Multi-institutional clinical reviews have documented the use of CEUS and SR-US platforms for adaptive microvascular monitoring within oncology settings. Physicians are increasingly utilizing these technologies to assess tumor angiogenesis in real time and modify therapeutic targeting strategies during active treatment procedures. In cardiovascular medicine, standardized protocols leveraging dual-phase delayed enhancement kinetics have enabled clinicians to evaluate Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) using lower-cost ultrasound and computed tomography systems. These approaches can differentiate myocarditis from myocardial scarring and identify high-risk arterial plaques shortly after acute cardiac events. Supporting this expanding clinical adoption, Bracco commissioned a new manufacturing facility dedicated to producing high-purity contrast agents, including advanced microbubble formulations used for tissue perfusion imaging, vascular assessment, and oncological visualization during real-time ultrasound procedures.

Contrast Enhanced Ultrasound (CEUS) Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Contrast Enhanced Ultrasound (CEUS) market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Bracco Imaging S.p.A., GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Lantheus Holdings, Inc., Canon Medical Systems Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Esaote S.p.A., Samsung Electronics Co., Ltd., Guerbet. The Contrast Enhanced Ultrasound (CEUS) market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Contrast Enhanced Ultrasound (CEUS) industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Contrast Enhanced Ultrasound (CEUS) Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Contrast Enhanced Ultrasound (CEUS) companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Contrast Enhanced Ultrasound (CEUS) markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Contrast Enhanced Ultrasound (CEUS) Market Competitive Benchmarking and Company Analysis

Leading companies in Contrast Enhanced Ultrasound (CEUS) industry include- Bracco Imaging S.p.A., GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Lantheus Holdings, Inc., Canon Medical Systems Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Esaote S.p.A., Samsung Electronics Co., Ltd., Guerbet. The Contrast Enhanced Ultrasound (CEUS) market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Contrast Enhanced Ultrasound (CEUS) Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Contrast Enhanced Ultrasound (CEUS) market remains one of the strongest-performing segments in the country.
The US Contrast Enhanced Ultrasound (CEUS) Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Contrast Enhanced Ultrasound (CEUS) market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Contrast Enhanced Ultrasound (CEUS) industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Contrast Enhanced Ultrasound (CEUS) markets

Canada's strong Contrast Enhanced Ultrasound (CEUS) sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Contrast Enhanced Ultrasound (CEUS) market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Contrast Enhanced Ultrasound (CEUS) Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Contrast Enhanced Ultrasound (CEUS) market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Contrast Enhanced Ultrasound (CEUS) population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Contrast Enhanced Ultrasound (CEUS) industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Contrast Enhanced Ultrasound (CEUS) market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Contrast Enhanced Ultrasound (CEUS) sales through 2034

France Contrast Enhanced Ultrasound (CEUS) companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Contrast Enhanced Ultrasound (CEUS) Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Contrast Enhanced Ultrasound (CEUS) distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Contrast Enhanced Ultrasound (CEUS) Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Contrast Enhanced Ultrasound (CEUS) market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Contrast Enhanced Ultrasound (CEUS) industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Contrast Enhanced Ultrasound (CEUS) industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Contrast Enhanced Ultrasound (CEUS) Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Contrast Enhanced Ultrasound (CEUS) market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Contrast Enhanced Ultrasound (CEUS) market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Contrast Enhanced Ultrasound (CEUS) Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Contrast Enhanced Ultrasound (CEUS) Market Segmentation

By Product Type
Diagnostic Ultrasound Equipment
Ultrasound Contrast Agents
By Technology Platform
Non-Targeted CEUS
Targeted CEUS
By Clinical Application
Cardiovascular Imaging
Hepatic & Biliary
Oncology
Renal and Urological Imaging
Obstetric and Gynecological Imaging
By End-User
Hospitals and Multi-Specialty Health Systems
Diagnostic Imaging Centers
Ambulatory Surgical Centers

Top Companies in Contrast Enhanced Ultrasound (CEUS) Industry

Bracco Imaging S.p.A.
GE HealthCare Technologies Inc.
Siemens Healthineers AG
Koninklijke Philips N.V.
Lantheus Holdings, Inc.
Canon Medical Systems Corporation
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Esaote S.p.A.
Samsung Electronics Co., Ltd.
Guerbet

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025